Daratumumab, Pomalidomide, and Dexamethasone (DPd) in Relapsed/Refractory Light Chain Amyloidosis Patients Previously Exposed to Daratumumab
Weill Medical College of Cornell University
Weill Medical College of Cornell University
City of Hope Medical Center
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center